Smoking, nicotine and neuropsychiatric disorders
The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
The pathophysiology of cigarette smoking and cardiovascular disease
Ambrose, J. A., & Barua, R. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.047 · Cited by 2,394 · cited 3×
“Sidestream smoke has a greater concentration of some toxic components (i.e. carbon monoxide, benzene, ammonia, and many carcinogens) than mainstream smoke (Phillips et al., 2003; Ambrose and Barua, 2004; Brownson et al., 1997).”
BackgroundThe debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 2×
“The mesocorticolimbic dopamine system (MDS, sometimes referred to as the reward system) is regarded as the main morphological substrate of reward and reinforcement in the brain (Wonnacott et al., 2005; Nestler and Carlezon, 2006).”
BackgroundFood reward: brain substrates of wanting and liking
Berridge, K. C. (1996) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00033-b · Cited by 1,901
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Amos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.109 · Cited by 1,310
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262 · cited 3×
“comorbidity of NIC dependence and other psychiatric disorders (Grant et al., 2004).”
BackgroundDamage to the insula disrupts addiction to cigarette smoking
Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007) · Science · doi:10.1126/science.1135926 · Cited by 1,245
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
Grace, A. A., Floresco, S. B., Goto, Y., & Lodge, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.003 · Cited by 1,034 · cited 11×
“All of these cell types send connections to the VTA (Wonnacott et al., 2005; Janhunen and Ahtee, 2007; Grace et al., 2007; Dani and Harris, 2005; Wonnacott, 2008; Maskos, 2008).”
BackgroundInfluentialSchultz, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.007 · Cited by 1,028
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events
Horvitz, J. C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00019-1 · Cited by 967
Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking
Barnoya, J., & Glantz, S. A. (2005) · Circulation · doi:10.1161/circulationaha.104.492215 · Cited by 939 · cited 1×
“Nevertheless, epidemiological investigations have clearly demonstrated the health risks of passive smoking, too (Swan and Lessov-Schlaggar, 2007; Barnoya and Glantz, 2005; Brownson et al., 1997; Venn and Britton, 2007; Subramanian and Govindan, 2007).”
BackgroundSmoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
The hidden island of addiction: the insula
Naqvi, N. H., & Bechara, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.009 · Cited by 833 · cited 3×
“associated with impaired amphetamine-conditioned place-preference (Contreras et al., 2007; Naqvi and Bechara, 2009).”
BackgroundGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678 · cited 1×
“regarding a7 nAChRs, since most investigations suggest the expression of a7 nAChRs is decreased in the hippocampus, the reticular nucleus of the thalamus, and the prefrontal cortex (Freedman et al., 1995; Court et al., 1999; Guan et al., 1999; Martin-Ruiz et al., 2003; Adams and Stevens, 2007; Olincy and Stevens, 2007…”
BackgroundTargeting acetylcholinesterase and butyrylcholinesterase in dementia
Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005833 · Cited by 654
Variants in Nicotinic Receptors and Risk for Nicotine Dependence
Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X., Saccone, N. L., Saccone, S. F., Bertelsen, S., Fox, L., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111711 · Cited by 648
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643
Oquendo, M. A., Galfalvy, H., Russo, S., Ellis, S. P., Grunebaum, M. F., Burke, A., & Mann, J. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1433 · Cited by 605
Nicotine amplifies reward-related dopamine signals in striatum
Rice, M. E., & Cragg, S. J. (2004) · Nature Neuroscience · doi:10.1038/nn1244 · Cited by 594 · cited 2×
“…cells in the VTA are in burst-firing mode in response to reward-predicting stimuli or in unpredicted-reward situations, NIC administration selectively enhances reward-related dopamine release (Britt and McGehee, 2008; Rice and Cragg, 2004; Exley et al., 2008; Schultz, 1997; Schultz, 2007).”
BackgroundEnvironmental risk factors for attention‐deficit hyperactivity disorder
Banerjee, T. D., Middleton, F., & Faraone, S. V. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00430.x · Cited by 575
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566
Neurobiologic processes in drug reward and addiction
Adinoff, B. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490910844 · Cited by 546 · cited 4×
“ethanol, opiates, cannabinoids, phencyclidine, toluene (in inhalant abuse) and psychostimulants) (Pierce and Kumaresan, 2006; Riegel et al., 2007; Adinoff, 2004; Rose, 2007; Hutson et al., 2000; Britt and McGehee, 2008; Melis et al., 2005).”
BackgroundResultInfluentialGoff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Elkins, I. J., McGue, M., & Iacono, W. G. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1145 · Cited by 480
Belmaker, R. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035354 · Cited by 473
PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 460 · cited 23×
“…the NIC self-administration paradigm were contradictory, which suggests that a4b2 receptors – compared with a7 receptors – have a bigger role in the mediation of rewarding effects of NIC (Laviolette and van der Kooy, 2003a,b, 2004; Picciotto et al., 2008; Fowler et al., 2008; Walters et al., 2006).”
BackgroundResultInfluentialHumor Modulates the Mesolimbic Reward Centers
Mobbs, D., Greicius, M. D., Abdel-Azim, E., Menon, V., & Reiss, A. L. (2003) · Neuron · doi:10.1016/s0896-6273(03)00751-7 · Cited by 440
Recent developments and current controversies in depression
Ebmeier, K. P., Donaghey, C., & Steele, J. D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67964-6 · Cited by 434 · cited 1×
“with an increased risk of disability and mortality (according to estimates by the WHO, depression will be the second leading cause of disability worldwide in 2020), is a common diagnosis worldwide with a life-time prevalence 5–17% (Rihmer and Angst, 2005; Chachamovich et al., 2008; Ebmeier et al., 2006).”
BackgroundDIAMOND, A. (2005) · Development and Psychopathology · doi:10.1017/s0954579405050388 · Cited by 428
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426 · cited 1×
“However, in a later phase-2 trial, investigators did not find any significant improvement in the cognitive functions of patients (but they found that DMXB-A has a therapeutic effect on the negative symptoms of schizophrenia) (Olincy et al., 2006, 2007; Freedman et al., 2008; Galletly, 2009).”
BackgroundFurey, M. L., & Drevets, W. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1121 · Cited by 417
Maternal smoking during pregnancy and psychiatric adjustment in late adolescence
Fergusson, D. M., Woodward, L. J., & Horwood, L. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.721 · Cited by 396
Effect of smoking history on [3H]nicotine binding in human postmortem brain
Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C., & Leonard, S. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36798-9 · Cited by 396
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393
Peng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391
Ji, H., & Shepard, P. D. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0958-07.2007 · Cited by 388 · cited 1×
“According to this structural connection, the electrical stimulation of neurons in the lateral habenula suppresses the activity of dopaminergic neurons in the VTA (Wonnacott et al., 2005; Hikosaka et al., 2008; Ji and Shepard, 2007; Morra, 2007; Lecourtier et al., 2008; Ungless, 2004).”
BackgroundSuicide risk in mood disorders
Rihmer, Z. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280106868 · Cited by 382
Self-citationNicotine addiction and comorbidity with alcohol abuse and mental illness
Dani, J. A., & Harris, R. A. (2005) · Nature Neuroscience · doi:10.1038/nn1580 · Cited by 382 · cited 5×
“All of these cell types send connections to the VTA (Wonnacott et al., 2005; Janhunen and Ahtee, 2007; Grace et al., 2007; Dani and Harris, 2005; Wonnacott, 2008; Maskos, 2008).”
BackgroundInfluentialMagnetic Resonance Spectroscopy
Gujar, S. K., Maheshwari, S., Bj??rkman-Burtscher, I., & Sundgren, P. C. (2005) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000177307.21081.81 · Cited by 380
Piasecki, T. M. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.11.007 · Cited by 370
Kollins, S. H., McClernon, F. J., & Fuemmeler, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1142 · Cited by 369 · cited 1×
“Not only clinical diagnosis of ADHD, but symptoms of ADHD correlate positively with smoking in nonclinical (community) samples (Kollins et al., 2005; Fuemmeler et al., 2007; Barman et al., 2004; Lerman et al., 2001; Tercyak et al., 2002; McClernon and Kollins, 2008).”
BackgroundNeurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Wooltorton, J. R. A., Pidoplichko, V. I., Broide, R. S., & Dani, J. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03176.2003 · Cited by 363 · cited 2×
“Desensitization of nAChRs in different cell types of VTA is also very important in the regulation of activity of the mesolimbic reward pathway by NIC (see discussion below) (Picciotto et al., 2008; Wooltorton et al., 2003; Keath et al., 2007; Dani and Harris, 2005).”
BackgroundFrequency-dependent modulation of dopamine release by nicotine
Zhang, H., & Sulzer, D. (2004) · Nature Neuroscience · doi:10.1038/nn1243 · Cited by 361 · cited 2×
“…a6b2* nAChRs are key players in the regulation of NIC-evoked dopamine release in the NAcc) (Janhunen and Ahtee, 2007; Britt and McGehee, 2008; Picciotto, 2003; Rice and Cragg, 2004; Zhang and Sulzer, 2004; Exley and Cragg, 2008; Exley et al., 2008; Mansvelder et al., 2003; Dani and Bertrand, 2007).”
BackgroundDesensitization of nicotinic ACh receptors: shaping cholinergic signaling
GINIATULLIN, R., NISTRI, A., & YAKEL, J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.04.009 · Cited by 357 · cited 6×
“…with markedly different velocities of desensitization in regard to the two main subtypes (in a range of seconds for a4b2 and milliseconds for a7) (Giniatullin et al., 2005; Léna and Changeux, 1998; Jacobsen et al., 2004; Prus et al., 2007; Robinson et al., 2006; Janhunen and Ahtee, 2007;…”
BackgroundInfluentialMorphine reward in dopamine-deficient mice
Hnasko, T. S., Sotak, B. N., & Palmiter, R. D. (2005) · Nature · doi:10.1038/nature04172 · Cited by 338
Smoking and structural brain deficits: a volumetric MR investigation
Gallinat, J., Meisenzahl, E., Jacobsen, L. K., Kalus, P., Bierbrauer, J., Kienast, T., Witthaus, H., Leopold, K., Seifert, F., Schubert, F., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05050.x · Cited by 330
Pathophysiology of hypercortisolism in depression
Carroll, B. J., Cassidy, F., Naftolowitz, D., Tatham, N. E., Wilson, W. H., Iranmanesh, A., Liu, P. Y., & Veldhuis, J. D. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.00967.x · Cited by 317 · cited 1×
“dysregulation of the hypothalamo–pituitary–adrenal (HPA) axis (Carroll et al., 2007).”
Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., & Fratta, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3918-08.2008 · Cited by 312 · cited 3×
“NIC self-administration is also impaired in a4 KO mice, but the lentiviral vector-mediated reexpression of a4 subunit in the VTA restored NIC self-administration in a4 KO mice strain (Pons et al., 2008).”
BackgroundSalas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310 · cited 1×
“…receptor subunits types in the medial habenula and/or in interpeduncular nucleus) show decreased somatic signs of nicotine withdrawal is in agreement with the idea that the habenular/interpeduncular system plays a major role in NIC dependence (Salas et al., 2009; De Biasi and Salas, 2008).”
ResultPremature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review
Roshanaei-Moghaddam, B., & Katon, W. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.2.147 · Cited by 305
Cigarette smoking and major depression
Covey, L. S., Glassman, A. H., & Stetner, F. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n01_04 · Cited by 302 · cited 1×
“In clinical smoking treatment studies, the life-time prevalence of major depression was much higher than in the general population (Covey et al., 1998).”
BackgroundInactivation of the Interoceptive Insula Disrupts Drug Craving and Malaise Induced by Lithium
Contreras, M., Ceric, F., & Torrealba, F. (2007) · Science · doi:10.1126/science.1145590 · Cited by 297 · cited 3×
“associated with impaired amphetamine-conditioned place-preference (Contreras et al., 2007; Naqvi and Bechara, 2009).”
BackgroundHierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors
Mameli-Engvall, M., Evrard, A., Pons, S., Maskos, U., Svensson, T. H., Changeux, J.-P., & Faure, P. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.007 · Cited by 296
The relationship between smoking status and cortisol secretion.
Badrick, E., Kirschbaum, C., & Kumari, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2155 · Cited by 284
Lecourtier, L., & Kelly, P. H. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.01.004 · Cited by 283 · cited 1×
“According to this structural connection, the electrical stimulation of neurons in the lateral habenula suppresses the activity of dopaminergic neurons in the VTA (Wonnacott et al., 2005; Hikosaka et al., 2008; Ji and Shepard, 2007; Morra, 2007; Lecourtier et al., 2008; Ungless, 2004).”
BackgroundNicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
Psychiatric disorders and stages of smoking
Breslau, N., Novak, S. P., & Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00317-2 · Cited by 274
Klungsøyr, O., Nygård, J. F., Sørensen, T., & Sandanger, I. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj058 · Cited by 269
Nicotine: from molecular mechanisms to behaviour
Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263 · cited 4×
“All of these cell types send connections to the VTA (Wonnacott et al., 2005; Janhunen and Ahtee, 2007; Grace et al., 2007; Dani and Harris, 2005; Wonnacott, 2008; Maskos, 2008).”
BackgroundInfluentialNicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261 · cited 2×
“, 2005; Wells, 2008); NIC acts in the ER as a ‘‘maturational enhancer’’ and promotes the transition from an immature oligomer receptor state into a state with higher metabolic stability (Sallette et al., 2005; Corringer et al., 2006; Gaimarri et al., 2007); NIC may decrease – both by a direct and a nAChR-mediated”
BackgroundNicotine as a modulator of behavior: beyond the inverted U
Picciotto, M. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00230-x · Cited by 257 · cited 2×
“…and frontal cortex (Pierce and Kumaresan, 2006; Janhunen and Ahtee, 2007; Mameli-Engvall et al., 2006; Rose, 2007; Dani and Harris, 2005; Bednar et al., 2004; Picciotto, 2003; Picciotto et al., 2008; Fowler et al., 2008; Mansvelder et al., 2006; Pidoplichko et al., 2004; Exley et al., 2008).”
BackgroundNeural substrates of abstinence-induced cigarette cravings in chronic smokers
Wang, Z., Faith, M., Patterson, F., Tang, K., Kerrin, K., Wileyto, E. P., Detre, J. A., & Lerman, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2966-07.2007 · Cited by 256 · cited 4×
“…cortex, visual cortex, and cerebellum) and these areas are also the key anatomical substrates of a wide range of cognitive processes (i.e. memory processes, attention, behavioral control, decision making, etc.) (Zubieta et al., 2005; Brody et al., 2007; Wang et al., 2007b; Tanabe et al., 2008).”
BackgroundInfluentialHistory of depression and smoking cessation outcome: A meta-analysis.
Hitsman, B., Borrelli, B., McChargue, D. E., Spring, B., & Niaura, R. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.657 · Cited by 253
Smoking in Patients Receiving Psychotropic Medications: A Pharmacokinetic Perspective
Desai, H. D., Seabolt, J., & Jann, M. W. (2001) · CNS Drugs · doi:10.2165/00023210-200115060-00005 · Cited by 253
Auquier, P., Lançon, C., Rouillon, F., Lader, M., & Holmes, C. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1325 · Cited by 249
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248
Asthma and Panic in Young Adults
Hasler, G., Gergen, P. J., Kleinbaum, D. G., Ajdacic, V., Gamma, A., Eich, D., Rössler, W., & Angst, J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1669oc · Cited by 248
Wiles, N. J., Zammit, S., Bebbington, P., Singleton, N., Meltzer, H., & Lewis, G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.012179 · Cited by 245
George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · cited 1×
“…et al., 2008; Rossi et al., 2005a,b; Grilli et al., 2005; Markou, 2007, 2008; Liechti and Markou, 2008; Kenny et al., 2009; Hahn and Stolerman, 2005; Erhardt et al., 2000; George et al., 2007; Xue and Domino, 2008; Chen et al., 2008b; Merritt et al., 2008; Pasumarthi and Fadel, 2008).”
BackgroundMcClernon, F. J., Kozink, R. V., Lutz, A. M., & Rose, J. E. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1436-9 · Cited by 244
Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242 · cited 3×
“…cells in the VTA are in burst-firing mode in response to reward-predicting stimuli or in unpredicted-reward situations, NIC administration selectively enhances reward-related dopamine release (Britt and McGehee, 2008; Rice and Cragg, 2004; Exley et al., 2008; Schultz, 1997; Schultz, 2007).”
BackgroundNeuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240
Smoking and suicide: A brief overview
Hughes, J. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.003 · Cited by 236
Regulation of Nicotinic Acetylcholine Receptor Numbers and Function by Chronic Nicotine Exposure
Gentry, C., & Lukas, R. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339184 · Cited by 232
Staley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E., Dubin, J. A., Estok, K., Brenner, E., Baldwin, R. M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0546-06.2006 · Cited by 229 · cited 2×
“…in humans have also confirmed both the upregulation of a4b2 receptors after chronic NIC administration (smoking) and the termination of upregulation after approximately 21 days of smoking cessation (Mamede et al., 2007; Staley et al., 2006; Wullner et al., 2008; Kassiou et al., 2001).”
BackgroundMid-life smoking and late-life dementia: the Honolulu-Asia Aging Study
Tyas, S. L., White, L. R., Petrovitch, H., Webster Ross, G., Foley, D. J., Heimovitz, H. K., & Launer, L. J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00156-2 · Cited by 226
Varenicline improves mood and cognition during smoking abstinence
Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.028 · Cited by 222 · cited 1×
“investigations (a recent article, however, reports that RJR-2403 (a4b2-selective agonist) and PNU-282987 (a7-selective agonist) lack efficacy in the forced swim test and the tail-suspension test in mice) (Picciotto et al., 2008; Philip et al., 2009; Lodge and Li, 2008; Patterson et al., 2009; George et al., 2008; Popi…”
BackgroundMykletun, A., Overland, S., Aarø, L. E., Liabø, H.-M., & Stewart, R. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2007.10.005 · Cited by 213 · cited 1×
“subsequent increase in the amount of smoking is more closely associated with a current mental disorder than a remitted one (Breslau et al., 2004b; John et al., 2004; Mykletun et al., 2008).”
BackgroundOddo, S., Caccamo, A., Green, K. N., Liang, K., Tran, L., Chen, Y., Leslie, F. M., & LaFerla, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408500102 · Cited by 211 · cited 1×
“In mouse models of AD, the expression levels of the a7 nAChR protein/mRNA in the brain are also unclear (levels are elevated in the hAChE-Tg, APPSWETg, and APPSWE/hAChE-Tg mouse strains, but decreased in the 3xTG-AD mouse strain) (Mousavi and Nordberg, 2006; Oddo et al., 2005).”
BackgroundFunctional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207 · cited 12×
“Discrepant results of this study are possibly due to the decreased selectivity of [123I]b-CIT to DAT compared with [99mTc] TRODAT (Staley et al., 2001; Brody, 2006).”
BackgroundMethodResultInfluentialWalters, C. L., Brown, S., Changeux, J.-P., Martin, B., & Damaj, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0295-x · Cited by 206 · cited 4×
“…but not in affective signs of NIC withdrawal (Portugal and Gould, 2008; Mineur and Picciotto, 2008; Jackson et al., 2008; Pons et al., 2008; Walters et al., 2006). b4 subunit KO rodents display decreased somatic signs (i.e. changes in grooming, chewing, scratching, and tremors) of NIC…”
BackgroundResultInfluentialSystematic Regional Variations in the Loss of Cortical Cholinergic Fibers in Alzheimer's Disease
Geula, C., & Mesulam, M.-M. (1996) · Cerebral Cortex · doi:10.1093/cercor/6.2.165 · Cited by 202 · cited 1×
“Relatively preserved cholinergic innervations of the thalamus (from the brainstem) and the striatum (from striatal interneurons) and some regions of cortex (anterior cingulum, primary visual, somatosensory and motor cortex) were reported in AD (Geula and Mesulam, 1996; Lane et al., 2006).”
BackgroundMcClernon, F. J., Kozink, R. V., & Rose, J. E. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301618 · Cited by 202
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
Vallejo, Y. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5240-04.2005 · Cited by 201
Nicotine Enhances Visuospatial Attention by Deactivating Areas of the Resting Brain Default Network
Hahn, B., Ross, T. J., Yang, Y., Kim, I., Huestis, M. A., & Stein, E. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5129-06.2007 · Cited by 199 · cited 1×
“The default system consists of the medial frontal area, posterior cingulate cortex, and (pre)cuneal region) (for details see Brody, 2006; Hahn et al., 2007; Musso et al., 2007; Swan and Lessov-Schlaggar, 2007; Xu et al., 2007; Ray et al., 2008; Schilbach et al., 2008).”
BackgroundPidoplichko, V. I., Noguchi, J., Areola, O. O., Liang, Y., Peterson, J., Zhang, T., & Dani, J. A. (2004) · Learning & Memory · doi:10.1101/lm.70004 · Cited by 196 · cited 3×
“…release in this stage too, which further activates dopaminergic cells of the VTA during prolonged NIC administration (i.e. smoking) (Janhunen and Ahtee, 2007; Dani and Harris, 2005; Picciotto et al., 2008; Fowler et al., 2008; Mansvelder et al., 2006; Pidoplichko et al., 2004; Keath et al., 2007).”
BackgroundRoles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · cited 4×
“…(b, g, e, d) subunits (Gotti et al., 2000). a5 and b3 subunits are unique in this classification because they carry neither the principal nor the complementary component of the ACh-binding site; consequently, they are considered accessory subunits (Gotti et al., 2007; Kuryatov et al., 2008).”
BackgroundInfluentialWilens, T. E., Haight, B. R., Horrigan, J. P., Hudziak, J. J., Rosenthal, N. E., Connor, D. F., Hampton, K. D., Richard, N. E., & Modell, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.027 · Cited by 193
Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189
Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188
Birkenaes, A. B., Opjordsmoen, S., Brunborg, C., Engh, J. A., Jonsdottir, H., Ringen, P. A., Simonsen, C., Vaskinn, A., Birkeland, K. I., Friis, S., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0614 · Cited by 185 · cited 1×
“Results of investigations from different parts of the world suggest that the higher mortality rate in this patient population is a consequence not only of frequent obesity, metabolic syndrome, alcohol and other substance use, and poor diet, but also of smoking (Roshanaei-Moghaddam and Katon, 2009; Garcia-Portilla et a…”
BackgroundIn vivo antioxidant status: A putative target of antidepressant action
Zafir, A., Ara, A., & Banu, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.010 · Cited by 183
Diaz, F. J., James, D., Botts, S., Maw, L., Susce, M. T., & De Leon, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00664.x · Cited by 179 · cited 2×
“ever and current smoking than individuals from the general population (Diaz et al., 2009).”
BackgroundSmoking and the Risk of Suicidal Behavior: A Prospective Study of a Community Sample
Breslau, N., Schultz, L. R., Johnson, E. O., Peterson, E. L., & Davis, G. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.328 · Cited by 175
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia
Marutle, A., Zhang, X., Court, J., Piggott, M., Johnson, M., Perry, R., Perry, E., & Nordberg, A. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00117-x · Cited by 175
Desensitized nicotinic receptors in brain
Wang, H., & Sun, X. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.09.003 · Cited by 175 · cited 5×
“This theory is supported by a mutation leading to decreased desensitization of the a7 receptor, which is accompanied by the premature death of animals with this mutation (Wang and Sun, 2005; Mudo et al., 2007).”
BackgroundInfluentialGalantamine for the treatment of cognitive impairments in people with schizophrenia
Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050724 · Cited by 170
Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment
Banasr, M., & Duman, R. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707783220929 · Cited by 169 · cited 1×
“In consonance with this, chronic stress and depression is associated with decreased hippocampal volume (Millan, 2006; Gershon et al., 2007; Banasr and Duman, 2007).”
BackgroundHigh Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers
Salokangas, R. K. R., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvã«¡hti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.632 · Cited by 164 · cited 2×
“Salokangas et al. (2000) found enhanced [18F]fluorodopa uptake in the basal ganglia among smokers, which suggests smoking-related, enhanced dopamine activity in the striatum (Salokangas et al., 2000).”
BackgroundWilens, T. E., & Decker, M. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.002 · Cited by 164
TERCYAK, K. P., LERMAN, C., & AUDRAIN, J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200207000-00011 · Cited by 162 · cited 1×
“Not only clinical diagnosis of ADHD, but symptoms of ADHD correlate positively with smoking in nonclinical (community) samples (Kollins et al., 2005; Fuemmeler et al., 2007; Barman et al., 2004; Lerman et al., 2001; Tercyak et al., 2002; McClernon and Kollins, 2008).”
BackgroundGazdzinski, S., Durazzo, T. C., Studholme, C., Song, E., Banys, P., & Meyerhoff, D. J. (2005) · Alcoholism: Clinical & Experimental Research · doi:10.1097/01.alc.0000175018.72488.61 · Cited by 160 · cited 3×
“…of NIC-induced blood–brain barrier damage) characterized by plasma fluid leaking into the parenchymal interstitial space was considered another possible culprit (the findings of Paul et al. (2008), however, challenge the vasogenic swelling theory) (Gazdzinski et al., 2005; Paul et al., 2008).”
BackgroundNicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154
Miwa, J. M., Stevens, T. R., King, S. L., Caldarone, B. J., Ibanez-Tallon, I., Xiao, C., Fitzsimonds, R. M., Pavlides, C., Lester, H. A., Picciotto, M. R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.025 · Cited by 154
Lee, J.-H., Lim, Y., Wiederhold, B. K., & Graham, S. J. (2005) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-005-6377-z · Cited by 153
Cigarette Smoking and Panic Psychopathology
Zvolensky, M. J., & Bernstein, A. (2005) · Current Directions in Psychological Science · doi:10.1111/j.0963-7214.2005.00386.x · Cited by 150
Cigarettes and suicide: a prospective study of 50,000 men
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.5.768 · Cited by 148
Jacobsen, L. K., Picciotto, M. R., Heath, C. J., Frost, S. J., Tsou, K. A., Dwan, R. A., Jackowski, M. P., Constable, R. T., & Mencl, W. E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2402-07.2007 · Cited by 147 · cited 2×
“…higher FA was also found in the anterior cortical white matter and the internal capsule of both adolescent smokers and adolescent non-smokers with prenatal exposure to cigarette smoke compared to adolescent non-smokers with no prenatal exposure to cigarette smoke (Jacobsen et al., 2007).”
BackgroundNicotinic treatment of Alzheimer’s disease
Newhouse, P. A., Potter, A., Kelton, M., & Corwin, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01069-6 · Cited by 146
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145 · cited 1×
“…and in the development and maintenance of NIC dependence, (see De Biasi and Salas, 2008; Di Matteo et al., 2007; Touiki et al., 2007, 2008; Seth et al., 2002; Galindo-Charles et al., 2008; Rossi et al., 2005a,b; Grilli et al., 2005; Markou, 2007, 2008; Liechti and Markou, 2008; Kenny et…”
BackgroundPharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited
Ladner, C. J., & Lee, J. M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199808000-00001 · Cited by 142
Marangell, L. B., Bauer, M. S., Dennehy, E. B., Wisniewski, S. R., Allen, M. H., Miklowitz, D. J., Oquendo, M. A., Frank, E., Perlis, R. H., Martinez, J. M., et al. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00369.x · Cited by 139
Maskos, U. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.5 · Cited by 139
Ostacher, M. J., Nierenberg, A. A., Perlis, R. H., Eidelman, P., Borrelli, D. J., Tran, T. B., Ericson, G. M., Weiss, R. D., & Sachs, G. S. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1210 · Cited by 137
Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137
Wilens, T. E., Adamson, J., Monuteaux, M. C., Faraone, S. V., Schillinger, M., Westerberg, D., & Biederman, J. (2008) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.162.10.916 · Cited by 136
Mukhin, A. G., Kimes, A. S., Chefer, S. I., Matochik, J. A., Contoreggi, C. S., Horti, A. G., Vaupel, D. B., Pavlova, O., & Stein, E. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.050716 · Cited by 135 · cited 3×
“rence of an upregulation of a4b2* nAChRs upon chronic nicotine exposure, normalization of a4b2* receptor density after a few weeks abstinence in smokers, and nearly complete saturation of brain a4b2* receptors during a typical daily pattern of smoking (Mamede et al., 2007; Brody et al., 2006b; Mukhin et al., 2008).”
BackgroundCosta, G., Abin-Carriquiry, J. A., & Dajas, F. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03087-0 · Cited by 134
Hapke, U., Schumann, A., Rumpf, H.-J., John, U., Konerding, U., & Meyer, C. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000188964.83476.e0 · Cited by 133
Mao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05011.x · Cited by 133
Reduced dopamine d1 receptor binding in the ventral striatum of cigarette smokers
Dagher, A., Bleicher, C., Aston, J. A. D., Gunn, R. N., Clarke, P. B. S., & Cumming, P. (2001) · Synapse · doi:10.1002/syn.1098 · Cited by 132
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · cited 12×
“…the NIC self-administration paradigm were contradictory, which suggests that a4b2 receptors – compared with a7 receptors – have a bigger role in the mediation of rewarding effects of NIC (Laviolette and van der Kooy, 2003a,b, 2004; Picciotto et al., 2008; Fowler et al., 2008; Walters et al., 2006).”
BackgroundMethodResultInfluentialMansvelder, H. D., De Rover, M., McGehee, D. S., & Brussaard, A. B. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.099 · Cited by 130
Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129
Paul, R., Grieve, S., Niaura, R., David, S., Laidlaw, D., Cohen, R., Sweet, L., Taylor, G., Clark, R., Pogun, S., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200701767829 · Cited by 129 · cited 4×
“…of NIC-induced blood–brain barrier damage) characterized by plasma fluid leaking into the parenchymal interstitial space was considered another possible culprit (the findings of Paul et al. (2008), however, challenge the vasogenic swelling theory) (Gazdzinski et al., 2005; Paul et al., 2008).”
BackgroundInfluentialRabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129
George, T. P., Sacco, K. A., Vessicchio, J. C., Weinberger, A. H., & Shytle, R. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b49e · Cited by 128 · cited 2×
“investigations (a recent article, however, reports that RJR-2403 (a4b2-selective agonist) and PNU-282987 (a7-selective agonist) lack efficacy in the forced swim test and the tail-suspension test in mice) (Picciotto et al., 2008; Philip et al., 2009; Lodge and Li, 2008; Patterson et al., 2009; George et al., 2008; Popi…”
BackgroundSmoking History and Cognitive Function in Middle Age From the Whitehall II Study
Sabia, S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1165 · Cited by 128
Caldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122
Bordia, T., Campos, C., Huang, L., & Quik, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140897 · Cited by 120
Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity
Rezvani, K., Teng, Y., Shim, D., & De Biasi, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3353-07.2007 · Cited by 113
Laviolette, S. R., & van der Kooy, D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1317-6 · Cited by 113
Smoking at age 18–20 and suicide during 26 years of follow-up—how can the association be explained?
Hemmingsson, T., & Kriebel, D. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg203 · Cited by 111 · cited 1×
“) the relationship was dissipated and was no longer significant (Hemmingsson and Kriebel, 2003).”
BackgroundSPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
McClernon, F. J., Hiott, F. B., Westman, E. C., Rose, J. E., & Levin, E. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0516-y · Cited by 106 · cited 1×
“investigations (a recent article, however, reports that RJR-2403 (a4b2-selective agonist) and PNU-282987 (a7-selective agonist) lack efficacy in the forced swim test and the tail-suspension test in mice) (Picciotto et al., 2008; Philip et al., 2009; Lodge and Li, 2008; Patterson et al., 2009; George et al., 2008; Popi…”
BackgroundBehavioral Teratogenicity Induced by Nonforced Maternal Nicotine Consumption
Paz, R., Barsness, B., Martenson, T., Tanner, D., & Allan, A. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301066 · Cited by 105 · cited 1×
“This association could be the consequence of NIC-evoked dramatic changes in the developing nervous system (Fergusson et al., 1998; Paz et al., 2007; Heath and Picciotto, 2009).”
BackgroundAdult ADHD and Substance Abuse: Diagnostic and Treatment Issues
Kalbag, A. S., & Levin, F. R. (2005) · Substance Use & Misuse · doi:10.1080/10826080500294858 · Cited by 104
Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain
Koylu, E., Demirgören, S., London, E. D., & Pöǧün, S. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00665-6 · Cited by 104
Cigarette smoking associated with attention deficit hyperactivity disorder
Wilens, T. E., Vitulano, M., Upadhyaya, H., Adamson, J., Sawtelle, R., Utzinger, L., & Biederman, J. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.04.030 · Cited by 103
Spina, L., Fenu, S., Longoni, R., Rivas, E., & Di Chiara, G. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0211-4 · Cited by 102 · cited 1×
“…disruption of dopaminergic neurons in reward pathway by 6- hydroxydopamine or the administration of dopamine antagonists is associated with decreased NIC self-administration and NICevoked conditioned place-preference (Laviolette and van der Kooy, 2004; Sellings et al., 2008; Spina et al., 2006).”
BackgroundAndreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101 · cited 1×
“investigations (a recent article, however, reports that RJR-2403 (a4b2-selective agonist) and PNU-282987 (a7-selective agonist) lack efficacy in the forced swim test and the tail-suspension test in mice) (Picciotto et al., 2008; Philip et al., 2009; Lodge and Li, 2008; Patterson et al., 2009; George et al., 2008; Popi…”
BackgroundDementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia
Martin-Ruiz, C. M., Haroutunian, V. H., Long, P., Young, A. H., Davis, K. L., Perry, E. K., & Court, J. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00348-2 · Cited by 100
Heath, C. J., & Picciotto, M. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.020 · Cited by 99 · cited 1×
“This association could be the consequence of NIC-evoked dramatic changes in the developing nervous system (Fergusson et al., 1998; Paz et al., 2007; Heath and Picciotto, 2009).”
BackgroundInfluence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95 · cited 7×
“…on the relevance of these diverse actions of NIC in various brain functions and in the development and maintenance of NIC dependence, (see De Biasi and Salas, 2008; Di Matteo et al., 2007; Touiki et al., 2007, 2008; Seth et al., 2002; Galindo-Charles et al., 2008; Rossi et al., 2005a,b;…”
BackgroundResultInfluentialSmoking impacts on prefrontal attentional network function in young adult brains
Musso, F., Bettermann, F., Vucurevic, G., Stoeter, P., Konrad, A., & Winterer, G. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0499-8 · Cited by 93 · cited 3×
“The default system consists of the medial frontal area, posterior cingulate cortex, and (pre)cuneal region) (for details see Brody, 2006; Hahn et al., 2007; Musso et al., 2007; Swan and Lessov-Schlaggar, 2007; Xu et al., 2007; Ray et al., 2008; Schilbach et al., 2008).”
BackgroundMethodTemporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study
Mamede, M., Ishizu, K., Ueda, M., Mukai, T., Iida, Y., Kawashima, H., Fukuyama, H., Togashi, K., & Saji, H. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043471 · Cited by 91
Regulation of neuronal nicotinic receptor traffic and expression
Gaimarri, A., Moretti, M., Riganti, L., Zanardi, A., Clementi, F., & Gotti, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.005 · Cited by 89 · cited 6×
“…the transition from an immature oligomer receptor state into a state with higher metabolic stability (Sallette et al., 2005; Corringer et al., 2006; Gaimarri et al., 2007); NIC may decrease – both by a direct and a nAChR-mediated manner – the process of protein degradation via modulation of…”
BackgroundInfluentialIs cigarette smoking associated with suicidal ideation among young people?
McGee, R., Williams, S., & Nada-Raja, S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.619 · Cited by 88
Up-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype
Walsh, H., Govind, A. P., Mastro, R., Hoda, J. C., Bertrand, D., Vallejo, Y., & Green, W. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m703432200 · Cited by 87 · cited 2×
“The upregulation characteristics of a3b2 receptors and the a4b2 receptors, measured in vitro, are also different from each other (Walsh et al., 2008).”
BackgroundCorringer, P.-J., Sallette, J., & Changeux, J.-P. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.012 · Cited by 86 · cited 6×
“(2004) found an increase in a7 immunoreactive perikarya in the granular cell layer of the dentate gyrus – but not in other brain regions – of smokers) (Teaktong et al., 2004; Nuutinen et al., 2005, 2006; Picciotto et al., 2008; Ochoa and Lasalde-Dominicci, 2007; Corringer et al., 2006).”
BackgroundInfluentialReview: Genetics of Attention Deficit/Hyperactivity Disorder
Wallis, D., Russell, H. F., & Muenke, M. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsn049 · Cited by 86 · cited 1×
“ADHD, while investigated polymorphisms of the CHRNA7 gene are not (Waldman and Gizer, 2006; McClernon and Kollins, 2008; Wallis et al., 2008).”
BackgroundVarenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study
Philip, N. S., Carpenter, L. L., Tyrka, A. R., Whiteley, L. B., & Price, L. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04441 · Cited by 86
Kessler, R. C., Borges, G., Sampson, N., Miller, M., & Nock, M. K. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.78 · Cited by 81
Rukstalis, M., Jepson, C., Patterson, F., & Lerman, C. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.002 · Cited by 78 · cited 1×
“impulsivity symptoms measured by a self-report checklist during smoking cessation (with nicotine replacement therapy) predict the increased likelihood of relapse (Rukstalis et al., 2005).”
MethodPerez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77
Dunbar, G. C., Inglis, F., Kuchibhatla, R., Sharma, T., Tomlinson, M., & Wamsley, J. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107066855 · Cited by 75
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania
Berk, M., Ng, F., Wang, W. V., Tohen, M., Lubman, D. I., Vieta, E., & Dodd, S. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.018 · Cited by 72
You, Z.-B., Wang, B., Zitzman, D., & Wise, R. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0694-08.2008 · Cited by 71 · cited 4×
“Neurobiological explanations of frequent co-occurrence of ADHD and smoking. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .”
BackgroundInfluentialAttention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders
Wilson, J. J., & Levin, F. R. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.751 · Cited by 71
Depressive Characteristics of FSL Rats
Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00236-7 · Cited by 70
Pietilä, K., Lähde, T., Attila, M., Ahtee, L., & Nordberg, A. (1998) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005152 · Cited by 67 · cited 1×
“…and ceases within 7 days in mice, 20 days in rats, and 8 weeks in humans after the termination of NIC administration in post-mortem studies (Picciotto et al., 2008; Mamede et al., 2007; Koylu et al., 1997; Pietilä et al., 1998; Sacco et al., 2004; Gentry and Lukas, 2002; Breese et al., 1997).”
BackgroundAge-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT
Mitsis, E. M., Cosgrove, K. P., Staley, J. K., Bois, F., Frohlich, E. B., Tamagnan, G. D., Estok, K. M., Seibyl, J. P., & van Dyck, C. H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.008 · Cited by 65 · cited 1×
“…nAChR availability between men and women non-smokers, and no change in b2* nAChR availability across the menstrual cycle (Brody et al., 2006b, 2009a; Staley et al., 2006; Cosgrove et al., 2007; Mamede et al., 2007; Mitsis et al., 2008; Mukhin et al., 2008; Ray et al., 2008; Wullner et al., 2008).”
BackgroundSmoking and Suicidal Behaviors in the National Comorbidity Survey: Replication
Kessler, R. C., Berglund, P. A., Borges, G., Castilla-Puentes, R. C., Glantz, M. D., Jaeger, S. A., Merikangas, K. R., Nock, M. K., Russo, L. J., & Stang, P. E. (2007) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3180303eb8 · Cited by 64 · cited 3×
“However, the ability of a mental disorder to predict a substance- (for example NIC) use disorder, has been more strongly substantiated (Kessler et al., 2007; Griesler et al., 2008; Glantz et al., 2009).”
BackgroundIwasaki, M., Akechi, T., Uchitomi, Y., & Tsugane, S. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.08.011 · Cited by 64
Kassiou, M., Eberl, S., Meikle, S. R., Birrell, A., Constable, C., Fulham, M. J., Wong, D. F., & Musachio, J. L. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00206-7 · Cited by 58 · cited 1×
“…in humans have also confirmed both the upregulation of a4b2 receptors after chronic NIC administration (smoking) and the termination of upregulation after approximately 21 days of smoking cessation (Mamede et al., 2007; Staley et al., 2006; Wullner et al., 2008; Kassiou et al., 2001).”
BackgroundSabbagh, M. N., Shah, F., Reid, R. T., Sue, L., Connor, D. J., Peterson, L. K. N., & Beach, T. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1771 · Cited by 57 · cited 1×
“In a recent study, epibatidine (a potent but non-selective nAChR agonist) binding was decreased in various parts of the cortex (Brodmann areas 38, 39 and 46) in AD but not in MCI compared with control subjects without dementia (Sabbagh et al., 2006; White et al., 2006; Yogeeswari et al., 2006).”
ResultHajek, P., McRobbie, H., & Gillison, F. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2006.10.005 · Cited by 52 · cited 1×
“According to the above data those NRT forms which provide rapid NIC release (e.g. nasal spray, chewing gum) have greater potential to cause behavioral dependence compared to NRT forms that provide slower NIC release (e.g. NIC patch) (Hajek et al., 2007; West et al., 2000).”
BackgroundHuman functional neuroimaging in nicotine and tobacco research: Basics, background, and beyond
McClernon, F. J., & Gilbert, D. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200412331337394 · Cited by 51
Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure
Lockman, P. R., McAfee, G., Geldenhuys, W. J., Van der Schyf, C. J., Abbruscato, T. J., & Allen, D. D. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085381 · Cited by 51
Rodriguez, D., Tercyak, K. P., & Audrain-McGovern, J. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm100 · Cited by 49
Cholinergic Circuits and Signaling in the Pathophysiology of Schizophrenia
Berman, J. A., Talmage, D. A., & Role, L. W. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78007-2 · Cited by 47 · cited 2×
“with schizophrenia compared to controls (Garcia-Rill et al., 1995; Adams and Stevens, 2007; Berman et al., 2007).”
Cotinine selectively activates a subpopulation of α3/α6β2* nicotinic receptors in monkey striatum
O’Leary, K., Parameswaran, N., McIntosh, J. M., & Quik, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136838 · Cited by 45
Significance of cigarette smoking among youths with bipolar disorder
Goldstein, B. I., Birmaher, B., Axelson, D. A., Goldstein, T. R., Esposito‐Smythers, C., Strober, M. A., Hunt, J., Leonard, H., Gill, M. K., Iyengar, S., et al. (2008) · The American Journal on Addictions · doi:10.1080/10550490802266151 · Cited by 44 · cited 3×
“sample of adolescents with bipolar disorder (Goldstein et al., 2008).”
ResultPerez, X. A., O’Leary, K. T., Parameswaran, N., McIntosh, J. M., & Quik, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053801 · Cited by 38
Cosgrove, K. P., Mitsis, E. M., Bois, F., Frohlich, E., Tamagnan, G. D., Krantzler, E., Perry, E., Maciejewski, P. K., Epperson, C. N., Allen, S., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042317 · Cited by 31 · cited 1×
“…nAChR availability between men and women non-smokers, and no change in b2* nAChR availability across the menstrual cycle (Brody et al., 2006b, 2009a; Staley et al., 2006; Cosgrove et al., 2007; Mamede et al., 2007; Mitsis et al., 2008; Mukhin et al., 2008; Ray et al., 2008; Wullner et al., 2008).”
BackgroundGalantamine as an Adjunctive Treatment in Major Depression
Elgamal, S., & MacQueen, G. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172756c · Cited by 25
Alzheimer's disease and smoking: bias in cohort studies
Debanne, S. M., Bielefeld, R. A., Cheruvu, V. K., Fritsch, T., & Rowland, D. Y. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11308 · Cited by 20
Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Wilens, T. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2059 · Cited by 16
Cited by
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453
Smoking and increased Alzheimer's disease risk: A review of potential mechanisms
Durazzo, T. C., Mattsson, N., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.009 · Cited by 451
Moylan, S., Jacka, F. N., Pasco, J. A., & Berk, M. (2013) · Brain and Behavior · doi:10.1002/brb3.137 · Cited by 186
“Smoking rates are significantly higher in anxietydisordered populations (Lasser et al. 2000; Tobias et al. 2008; Lawrence et al. 2010), and numerous studies support a relationship between cigarette smoking and psychiatric disorders (see review Dome et al. 2010).”
BackgroundLauterstein, D., Tijerina, P., Corbett, K., Akgol Oksuz, B., Shen, S., Gordon, T., Klein, C., & Zelikoff, J. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13040417 · Cited by 99
“Such modifications have been related to the development of certain mental health disorders such as schizophrenia and major depressive disorder [12,13].”
BackgroundGates, J., Killackey, E., Phillips, L., & Álvarez-Jiménez, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00213-8 · Cited by 72
Metadata
- Authors
- Dome, P., Lazary, J., Kalapos, M. P., & Rihmer, Z.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 34
- Issue
- 3
- Pages
- 295-342
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2081159649
- Cited by
- 217
- References
- 196
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.